Workflow
恒瑞医药、宁德时代通过港交所上市聆讯 多家A股公司拟赴港上市
news flash·2025-05-08 23:28

Core Viewpoint - A-share companies are increasingly interested in the "A+H" listing model, with several firms announcing plans to list in Hong Kong, driven by the establishment of a fast-track process for high-market-cap A-share companies by the Hong Kong Stock Exchange and the ongoing internationalization strategies of A-share enterprises [1] Group 1 - Heng Rui Medicine (600276) and Ningde Times (300750) have officially passed the listing hearing of the Hong Kong Stock Exchange [1] - Other A-share companies such as Silis (601127), Zhaowei Electromechanical (003021), and Dongpeng Beverage (605499) have also announced plans to list in Hong Kong [1] - The "A+H" listing model is gaining popularity, providing strong momentum for the development of the Hong Kong IPO market [1]